Skip to content
RDL Network logo
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial — Meletios A Dimopoulos (2023) | RDL Network